Gb Sciences Starts Preclinical Study for Plant-Based Formulas to Treat Depression and Anxiety

Nov 1, 2021

The biopharma technology company's AI-driven PhAROS™ platform has identified novel, plant-inspired formulations that will be tested using preclinical Zebrafish models at the National Research Council of Canada.


GB Sciences


LAS VEGAS - November 1, 2021 - (Newswire.com)

Gb Sciences, Inc. ("GbS"; OTCQB:GBLX), a leading plant-inspired research and biopharmaceutical drug development company, has initiated new preclinical studies at the National Research Council of Canada ("NRC") through GbS' Canadian subsidiary, GbS Global Biopharma, Inc. The NRC will test GbS' proprietary, psychotropic plant-based formulas for the treatment of depression and anxiety. GbS has leveraged its patent-pending PhAROS™ (Phytomedical Analytics for Research Optimization at Scale) platform to identify these combinations of plant compounds for novel drug candidates to treat depression and anxiety. These are the company's first non-cannabis formulations to enter preclinical studies.

The PhAROSTM platform is a revolutionary, AI-driven science gateway and virtual research environment for drug discovery. With its data analytics and machine learning capabilities, PhAROS™ allows Gb Sciences to greatly reduce the time and money required to bring novel, plant-inspired formulations to market. PhAROS™ represents a breakthrough combination of data sciences and traditional plant-based medicines. 

"Using AI pushes biomedical research forward past simplistic approaches to drug design because computer modeling of complex human diseases allows for the identification of suitably complex, multi-ingredient treatments," said Dr. Andrea Small-Howard, Gb Sciences' President and Chief Science Officer. "Our PhAROS™ platform yields numerous concrete, potentially-effective, plant-inspired combination drugs. This now includes formulations designed to help the millions of people around the world who are affected by depression and anxiety."

For these novel psychotropic drug candidates, the Gb Sciences research team used the PhAROS™ platform to identify new ingredients to improve upon an initial formulation for anxiety based on traditional medicine. The original plant mixture was derived from the kava plant, but some elements of kava are thought to cause liver toxicity. PhAROS™ identified ingredients from the Piper plant family as a substitute for the functionality of the ingredients in question without the potentially adverse safety profiles of those original ingredients. The Piper plant family includes pepper plants that are used worldwide in traditional medicines.

GbS' new psychotropic formulations are currently in preclinical trials at the Zebrafish Toxicology, Genomics and Neurobiology Lab at the NRC, led by Dr. Lee Ellis, Research Officer and Team Lead. The ongoing work between the NRC and Gb Sciences has produced strong and applicable data for the evaluation of its therapies, and this trial could provide novel treatment options for patients with depression and anxiety.

To learn more about Gb Sciences, visit www.gbsciences.com.

About Gb Sciences and GbS Global Biopharma

Gb Sciences, Inc. is a plant-based research and biopharma drug development company creating patented, disease-targeted formulations of plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc.. The "plant-inspired" active ingredients in its therapeutic mixtures are synthetic homologues identical to the original plant compounds but produced under current Good Manufacturing Practices. Gb Sciences' novel drug discovery platform has yielded five issued U.S. and three issued international patents, as well as 21 U.S. and 42 international patent-pending applications. In its drug development pipeline, the company has four preclinical-stage programs, and its lead Parkinson's disease therapeutic program is being prepared for a First-in-Man clinical trial. In addition to Parkinson's disease, Gb Sciences is developing therapeutics for COVID-related cytokine release syndrome (CRS), chronic pain, anxiety, depression, Mast Cell Activation Syndrome (MCAS), and heart failure. Gb Sciences' productive research and development network includes distinguished universities, hospitals, and Contract Research Organizations. To learn more, visit www.gbsciences.com.

Media Contact

Savannah Muir
[email protected]




Press Release Service by Newswire.com

Original Source: Gb Sciences Starts Preclinical Study for Plant-Based Formulas to Treat Depression and Anxiety

More News

Whistleblower alleges millions of Driscoll’s berries sent to Canada with excess chemical levels
Sep 26, 2026
Whistleblower alleges millions of Driscoll’s berries sent to Canada with excess chemical levels

A whistleblower lawsuit in California is alleging millions of pounds of Driscoll's fruit containing non-compliant levels of pesticides and chemicals crossed the border into Canada, and the company tried to cover it up.

This medical device heading to space with Joshua Kutryk is also helping people here on Earth
Sep 26, 2026
This medical device heading to space with Joshua Kutryk is also helping people here on Earth

On Oct. 1 Canadian Space Agency astronaut Joshua Kutyrk will blast off from Cape Canaveral, Fla., and he’s bringing some innovative Canadian tech with him.

The EU Just Asked Canada If We Could Be Best Buddies...Legally, And Canadians Are Responding In The Most Hilarious Way
Sep 26, 2026
The EU Just Asked Canada If We Could Be Best Buddies...Legally, And Canadians Are Responding In The Most Hilarious Way

Give me a baguette, a ciggy, and an espresso any day. View Entire Post ›

Travel leaders gather in the Maldives for World Travel Awards
Sep 26, 2026
Travel leaders gather in the Maldives for World Travel Awards

The Maldives is preparing to welcome travel and tourism leaders from across the region for the World Travel Awards Asia, Oceania & Indian Ocean Gala Ceremony 2026, powered by Bank of Maldives. The ceremony will take place at CROSSROADS Maldives on Sunday, 27 September 2026, coinciding with World Tourism Day. The evening will bring together leading travel, tourism and hospitality brands from across Asia, Oceania and the Indian Ocean to celebrate excellence across a wide range of categories, including hotels, resorts, airlines, tour operators, destinations and tourism attractions.

Fari Islands Festival 2026 brings together creativity, culture, wellness and conservation
Sep 26, 2026
Fari Islands Festival 2026 brings together creativity, culture, wellness and conservation

The Maldives’ Fari Islands archipelago came alive from 13–15 August as the second edition of the Fari Islands Festival unfolded across Patina Maldives and The Ritz-Carlton Maldives. Guided by its ‘One Festival, Every Sense’ philosophy, the festival welcomed an international community of artists, cultural voices, chefs, musicians, wellness practitioners and conservationists, including headline contributor Rosamund Pike and acclaimed designer Sean Wotherspoon.

Travel Tech Leaders Agree: Artificial Intelligence Will Transform Tourism
Sep 26, 2026
Travel Tech Leaders Agree: Artificial Intelligence Will Transform Tourism

On September 27th, UN Tourism celebrates World Tourism Day. In 2026, it will centre on how digitalization and Artificial Intelligence are redesigning tourism. To mark the date, Belvera Partners, a PR firm exclusively focused on supporting B2B travel technology companies, has brought together thought leaders across the travel technology ecosystem to explore the opportunities, challenges, and responsibilities associated with the rapid adoption of technology, in general, and AI, in particular, across hospitality, distribution, and travel experiences.

Brazil sees 14.03% increase in European tourists in 2026; British arrivals reach highest volume in 1
Sep 26, 2026
Brazil sees 14.03% increase in European tourists in 2026; British arrivals reach highest volume in 1

European visitors to Brazil is experiencing its best January-to-August period in two decades. In the first eight months of 2026, the country recorded 1.28 million tourist arrivals from Europe, a 14.03% increase compared to the same period in 2025.

China commits to ‘global gateway’ WTM London with largest-ever pavilion and extensive line-up
Sep 26, 2026
China commits to ‘global gateway’ WTM London with largest-ever pavilion and extensive line-up

The China Pavilion at this year’s WTM London will be almost 22% bigger than last year, with the stand configured to combine live cultural experiences, destination discovery and high-value business networking across all the three days of the world’s most influential travel and tourism event, powered by RX Global. The expanded footprint reflects the importance China places on rebuilding international tourism links through WTM London, while deepening cooperation with the UK and wider global travel trade.

Endless Trails: Discover Lithuania’s Wild Side on Foot
Sep 26, 2026
Endless Trails: Discover Lithuania’s Wild Side on Foot

Beyond Lithuania’s cities lies a landscape of quiet drama: ancient forests, misty bogs, glacial lakes and dunes shaped by the Baltic winds. Best explored on foot, these wild places offer a different side of Europe — one where you can walk for hours through seemingly untouched landscapes and still be back in town by evening. The Baltic nation is attracting growing international interest with an impressive 74% of visitors. Beyond its historic cities, cultural attractions and increasingly acclaimed food scene, Lithuania offers another compelling reason to visit: an extraordinary variety of accessible natural landscapes and its dynamic seasonality.

Cincy Region On The Rise: British Airways Expands Daily Service For Summer 2027
Sep 26, 2026
Cincy Region On The Rise: British Airways Expands Daily Service For Summer 2027

The Cincy Region is set for an even stronger connection with the UK in 2027, as British Airways announces a significant expansion of its nonstop service between London Heathrow and Cincinnati/Northern Kentucky International Airport (CVG).

Polar travel signals a shift in premium tourism
Sep 26, 2026
Polar travel signals a shift in premium tourism

Polar expedition travel is highlighting a broader shift in premium tourism, as travellers increasingly seek access, expertise and deeper experiences rather than scale, according to Sam Seward, President of Quark Expeditions, in the latest episode of the Travel Trends Podcast. Speaking to Travel Trends host Dan Christian, Seward describes a market where both booking behaviour and traveller expectations are changing – from earlier bookings for Antarctica to growing demand for specialist experiences such as photography, kayaking and citizen science.

How one woman is rewriting kabuki’s ‘all-male’ narrative in Japan
Sep 26, 2026
How one woman is rewriting kabuki’s ‘all-male’ narrative in Japan

Out of the backstage shadows, an onnagata – the traditional female role in the Japanese traditional theatre art of kabuki – steals into the light. Her hair is swept high into a voluminous bun, framing a face veiled in a thin layer of porcelain-white powder. Touches of cherry blossom flush across her eyelids and lips. She glides across the starkly lit stage so weightlessly that her steps leave silence behind. With precision, she turns, twirls and looks into the distance, face perfectly...

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Daily Travelogue

In Daily Travelogue, we aim to provide rich content for the budget traveler. We only publish blog post that is informative and entertaining to add value to our readers’ user experience.

Newsletter